Phantom Neuro Raises $28M Series A to Revolutionize Prosthetic Technology with the Minimally Invasive Phantom X

Phantom Neuro is thrilled to announce a landmark funding milestone of $28,000,000, marking a significant turning point in the company’s journey toward reshaping medical technology for individuals with function-limiting injuries. This momentous investment not only underscores the confidence that investors have in our groundbreaking approach but also fuels our mission to enhance human capability through innovation. At the heart of Phantom Neuro’s vision is the development of the Phantom X, the world’s first minimally invasive peripheral neural interface. By integrating state-of-the-art technology with the human nervous system, Phantom X is designed to allow complex electronic systems—such as advanced prosthetic limbs—to function as if they were natural extensions of the body. This revolutionary technology has the potential to drastically improve the quality of life for countless individuals by restoring movement and functionality in ways that were previously thought unattainable. This new influx of capital will be strategically deployed to accelerate the refinement of our proprietary interface, expand our research and development capabilities, and streamline the path to regulatory approval. Additionally, funds will support our initiatives to collaborate with leading experts in the biomedical and engineering fields, ensuring that we remain at the cutting edge of neural interface technology. As a team of forward-thinking innovators motivated by a singular purpose—to help people overcome physical challenges—we are more committed than ever to pushing the boundaries of what is possible. This funding round not only validates our work so far but also opens up exciting opportunities for future advancements in prosthetic technology, ultimately setting the stage for a new era of human-technology integration.